Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI).
Lorente-Rovira E, Grasa E, Ochoa S, Corripio I, Peláez T, López-Carrilero R, Gutiérrez-Gea Á, Morano-Guillén M, Villagrán JM, Bartels-Velthuis AA, Jenner JA, Sanjuán J. Lorente-Rovira E, et al. Among authors: grasa e. Rev Psiquiatr Salud Ment (Engl Ed). 2020 May 31:S1888-9891(20)30027-6. doi: 10.1016/j.rpsm.2020.03.002. Online ahead of print. Rev Psiquiatr Salud Ment (Engl Ed). 2020. PMID: 32493672 English, Spanish.
Density of striatal D2 receptors in untreated first-episode psychosis: an I123-IBZM SPECT study.
Corripio I, Escartí MJ, Portella MJ, Pérez V, Grasa E, Sauras RB, Alonso A, Safont G, Camacho MV, Dueñas R, Arranz B, San L, Catafau AM, Carrió I, Alvarez E. Corripio I, et al. Among authors: grasa e. Eur Neuropsychopharmacol. 2011 Dec;21(12):861-6. doi: 10.1016/j.euroneuro.2011.03.004. Epub 2011 Apr 5. Eur Neuropsychopharmacol. 2011. PMID: 21470832
The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: iodine-123-iodobenzamide single photon emission computed tomography study.
Corripio I, Ferreira A, Portella MJ, Pérez V, Escartí MJ, Del Valle Camacho M, Sauras RB, Alonso A, Grasa EM, Carrió I, Catafau AM, Alvarez E. Corripio I, et al. Among authors: grasa em. Psychiatry Res. 2012 Jan 30;201(1):73-7. doi: 10.1016/j.pscychresns.2011.02.004. Epub 2012 Jan 26. Psychiatry Res. 2012. PMID: 22281201
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.
Pina-Camacho L, Díaz-Caneja CM, Saiz PA, Bobes J, Corripio I, Grasa E, Rodriguez-Jimenez R, Fernández M, Sanjuán J, García-López A, Tapia-Casellas C, Álvarez-Blázquez M, Fraguas D, Mitjans M, Arias B, Arango C. Pina-Camacho L, et al. Among authors: grasa e. Rev Psiquiatr Salud Ment. 2014 Oct-Dec;7(4):166-78. doi: 10.1016/j.rpsm.2014.05.004. Epub 2014 Oct 19. Rev Psiquiatr Salud Ment. 2014. PMID: 25440735 English, Spanish.
Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations.
Alonso-Solís A, Vives-Gilabert Y, Grasa E, Portella MJ, Rabella M, Sauras RB, Roldán A, Núñez-Marín F, Gómez-Ansón B, Pérez V, Alvarez E, Corripio I. Alonso-Solís A, et al. Among authors: grasa e. Schizophr Res. 2015 Feb;161(2-3):261-8. doi: 10.1016/j.schres.2014.10.047. Epub 2014 Nov 20. Schizophr Res. 2015. PMID: 25468173
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
Cuesta MJ, Sánchez-Torres AM, Cabrera B, Bioque M, Merchán-Naranjo J, Corripio I, González-Pinto A, Lobo A, Bombín I, de la Serna E, Sanjuan J, Parellada M, Saiz-Ruiz J, Bernardo M; PEPs Group. Cuesta MJ, et al. Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. Epub 2015 Mar 26. Schizophr Res. 2015. PMID: 25819935
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
Mas S, Gassó P, Lafuente A, Bioque M, Lobo A, Gonzàlez-Pinto A, Olmeda MS, Corripio I, Llerena A, Cabrera B, Saiz-Ruiz J, Bernardo M; PEPs GROUP. Mas S, et al. Pharmacogenomics J. 2016 Oct;16(5):439-45. doi: 10.1038/tpj.2016.44. Epub 2016 Jun 7. Pharmacogenomics J. 2016. PMID: 27272046
Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study.
Huerta-Ramos E, Escobar-Villegas MS, Rubinstein K, Unoka ZS, Grasa E, Hospedales M, Jääskeläinen E, Rubio-Abadal E, Caspi A, Bitter I, Berdun J, Seppälä J, Ochoa S, Fazekas K; M-RESIST Group; Corripio I, Usall J. Huerta-Ramos E, et al. Among authors: grasa e. JMIR Mhealth Uhealth. 2016 Sep 28;4(3):e112. doi: 10.2196/mhealth.5716. JMIR Mhealth Uhealth. 2016. PMID: 27682896 Free PMC article.
Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.
Alonso-Solís A, Vives-Gilabert Y, Portella MJ, Rabella M, Grasa EM, Roldán A, Keymer-Gausset A, Molins C, Núñez-Marín F, Gómez-Ansón B, Alvarez E, Corripio I. Alonso-Solís A, et al. Among authors: grasa em. Schizophr Res. 2017 Nov;189:97-103. doi: 10.1016/j.schres.2017.01.042. Epub 2017 Jan 28. Schizophr Res. 2017. PMID: 28139359
61 results